Science

1

COPD Advanced Pathophysiology Analysis

Gloria B. Gallegos

Nursing Department, Miami Regional University

MSN5150 FNP1 B: Pathophysiology

Dr. Pavel De La Noval

October 5, 2025

Introduction

Chronic obstructive pulmonary disease (COPD) is a complex respiratory condition characterized by progressive airflow limitation and chronic lung inflammation caused by exposure to irritants and rarely genetic factors. It is an umbrella term for obstructive lung diseases including emphysema and/or chronic bronchitis. This disease is common, preventable, and treatable requiring careful analysis by a specialized clinician.

It is crucial to understand the pathophysiology of COPD to create a plan of care that targets the root cause. It will depend on the many factors such as, the patient’s age, living/work environment, genetics, habits, and lifestyle. These are just a few factors that must be analyzed and require follow up to improve quality of life and prevent premature death.

Literature Review

Chronic obstructive pulmonary disease (COPD) is a common, preventable, and treatable lung disease characterized by consistent airflow limitations and inflammation of the alveoli and/or airway. This disease is caused by inhaled or exposure to irritants or genetic factors such as alpha-1 antitrypsin deficiency. This disease often includes Emphysema, or damaged alveoli, and chronic bronchitis, or excess mucus and chronic productive cough (Rogers & Brashers, 2022 pp. 1172-1173).

At the molecular level, there is an increase in neutrophils, macrophages, and T-lymphocytes in the lung in the attempt to clear irritants and pathogens. This causes further damage to lungs by inflammation, oxidative stress, and cell death by apoptosis and autophagy leading to lung tissue destruction (Rogers & Brashers, 2022 p.1173). In emphysema, neutrophil elastase and matrix metalloproteinases damage alveolar walls by breaking elastin fibers causing air to be trapped when exhaling thus increasing carbon dioxide and decreasing oxygen in the blood (Adcock et al., 2024). In the case of chronic bronchitis, cytokines cause an inflammation cascade pathway such as the tumor necrosis factor-alpha (TNF) and components like Lipopolysaccharide damaging epithelial cells (Zhang et al., 2024). Without these cells, the lungs lose their physical barrier against inhaled irritants and experience an increase of cells producing mucous, enlargement of mucous glands, and impaired mucus clearance reducing adequate gas exchange (Rogers & Brashers, 2022 p.1174).

One well known genetic factor contributing to COPD is alpha-1 antitrypsin deficiency (AATD). In this hereditary condition, low levels of this protective protein component circulate in the lungs creating an imbalance. In this case, neutrophil elastase cannot be neutralized and breaks down lung tissue leading to the development of emphysema before 40 years of age (Rogers & Brashers, 2022 p.1174).

One of the primary factors of COPD development is cigarette smoking which can modify existing proteins negatively affecting the lungs’ physical line of defense. Chronic inflammation, oxidative stress, airway remodeling, and increased mucous secretion are a few negative effects making the lungs susceptible to infections and lung tissue scarring or death. Other environmental factors that cause COPD include air pollution, temperature extremes, and exposure to chemicals.

Clinical Correlation

In recent studies, it has been proven that the mentioned molecular pathways identified in COPD correlates with the patient’s signs and symptoms. For example, the chronic inflammation caused by neutrophils, macrophages, and T-cells destroys the lung tissues. When is neutrophil elastase, this shows in patients as dyspnea and exercise intolerance because of the loss in elasticity of the alveoli limiting gas exchange. In macrophage activation and ongoing cytokine release leads to mucous hypersecretion and airway causing chronic bronchitis. This is manifested as wheezing and productive cough (Wang et al., 2025). Endothelial damage and oxidative stress further exacerbate the signs and symptoms of COPD and present as fatigue and muscle wasting like the diaphragm and intercostal muscles (Chen et al., 2025).

Understanding COPD’s molecular pathophysiology in a deeper level guides clinicians when conducting the assessment, diagnosis, and make accurate treatment decisions. The clinician may run the blood tests revealing inflammatory components. For example, in patients with eosinophil counts benefit from therapies like inhaled corticosteroids (Chen at al., 2025).